A Trial to Learn if REGN7999 is Safe and Well Tolerated, and How it Works in the Body of Healthy Participants
Clinical trial NCT05481333 · COMPLETED
Trial details
- NCT number
- NCT05481333
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-24
- Primary completion
- 2023-08-29
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.